AI-Designed Broad Coronavirus Vaccine Clears First Human Safety Trial
2h
1
Researchers reported phase 1 results on June 13, 2026, showing an AI-designed "universal" Sarbeco coronavirus vaccine was safe and triggered immune responses in 39 healthy volunteers. Fox News
